VVOS
Vivos Therapeutics Inc (VVOS)
Healthcare • NASDAQ • $0.66+0.18%
- Symbol
- VVOS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $0.66
- Daily Change
- +0.18%
- Market Cap
- $9.05M
- Trailing P/E
- N/A
- Forward P/E
- -1.90
- 52W High
- $7.95
- 52W Low
- $0.65
- Analyst Target
- $2.42
- Dividend Yield
- N/A
- Beta
- 6.21
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company wa…
Company websiteResearch VVOS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.